Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo‐ and Racemic Praziquantel: Two Phase I Studies-Reference-Cited by-同舟云学术

Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo‐ and Racemic Praziquantel: Two Phase I Studies

Published:2018-12-21 Issue:1 Volume:12 Page:66-76
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Bagchus Wilhelmina Maria¹,Bezuidenhout Deon²,Harrison‐Moench Eleanor³,Kourany‐Lefoll Elly⁴,Wolna Peter⁵,Yalkinoglu Oezkan³

Affiliation:

1. Quantitative Pharmacology Merck Institute for Pharmacometrics (an affiliate of Merck KGaA, Darmstadt, Germany) Lausanne Switzerland

2. Merck KGaA Modderfontein South Africa

3. Quantitative Pharmacology Merck KGaA Darmstadt Germany

4. Global Health Institute Ares Trading S.A. Coinsins Switzerland

5. Global Biostatistics Merck KGaA Darmstadt Germany

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12601

Reference23 articles.

1. Schistosomiasis: progress and problems

2. World Health Organization [Internet].World Health Organization Geneva c2016. Fact Sheet No. 115: Schistosomiasis. [about 6 screens]. (2016). Accessed 6 December 2016.

3. Human schistosomiasis

4. World Health Organization [Internet]. World Health Organization Geneva c2016. Schistosomiasis: Strategy. (2017) Accessed 17 February 2017.

5. World Health Organization.Report of a meeting to review the results of studies on the treatment of schistosomiasis in preschool‐age children.32(World Health Organization Geneva 2011). .

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Praziquantel Fifty Years on: A Comprehensive Overview of Its Solid State;Pharmaceutics;2023-12-24

2. Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial;The Lancet Infectious Diseases;2023-07

3. Metabolism of (R)‐Praziquantel versus the Activation of a Parasite Transient Receptor Potential Melastatin Ion Channel;ChemMedChem;2023-06-15

4. Vermifuge and vermicide drugs;Medicinal Chemistry of Chemotherapeutic Agents;2023

5. Current Status of Pharmacokinetic Research in Children: A Systematic Review of Clinical Trial Records;Current Reviews in Clinical and Experimental Pharmacology;2022-12-23